Iris launches eqTrader

Iris Financial Systems, a provider of trading and risk management systems based in San Francisco, today launched eqTrader, a component-based equity portfolio management system, onto the European market. eqTrader enables portfolio managers to automate their investment process, from trade-list generation to execution, while allowing them to check their risk exposures and returns on a real-time basis.

eqTrader is aimed at hedge funds and portfolio managers that have a high quantitative bias. As well as providing a complete front-to-back end solution, eqTrader allows funds to customise various components according to their individual needs.

Martin Gorrod, senior business consultant at Iris, said the product was aimed at funds that have a mechanised or highly model-based strategy, such as statistical arbitrage funds. The product was launched two years ago in the US, though it has only been taken up by three or four hedge funds so far, according to Gorrod. One of these is Iris’s sister company EVA Associates, a US-based statistical arbitrage fund.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here